SMAD7 expression was significantly different (p value < 0.05) across all three survival metrics, with an HR > 1 for OS and RFS and an HR < 1 for PPS, suggesting a complex relationship between its expression levels and colorectal cancer patient outcomes that warrants further investigation. The gene discussed is SMAD7; the disease is colorectal cancer.